Guzel, E.; Hanta, I.; Baydar Toprak, O.; Gurbuz, O.; Mete, B.; Bayram, E.
Risk Factors and Biomarkers for Pulmonary Toxicities Associated with Immune Checkpoint Inhibitors. Medicina 2025, 61, 1258.
https://doi.org/10.3390/medicina61071258
AMA Style
Guzel E, Hanta I, Baydar Toprak O, Gurbuz O, Mete B, Bayram E.
Risk Factors and Biomarkers for Pulmonary Toxicities Associated with Immune Checkpoint Inhibitors. Medicina. 2025; 61(7):1258.
https://doi.org/10.3390/medicina61071258
Chicago/Turabian Style
Guzel, Efraim, Ismail Hanta, Oya Baydar Toprak, Okan Gurbuz, Burak Mete, and Ertugrul Bayram.
2025. "Risk Factors and Biomarkers for Pulmonary Toxicities Associated with Immune Checkpoint Inhibitors" Medicina 61, no. 7: 1258.
https://doi.org/10.3390/medicina61071258
APA Style
Guzel, E., Hanta, I., Baydar Toprak, O., Gurbuz, O., Mete, B., & Bayram, E.
(2025). Risk Factors and Biomarkers for Pulmonary Toxicities Associated with Immune Checkpoint Inhibitors. Medicina, 61(7), 1258.
https://doi.org/10.3390/medicina61071258